56 related articles for article (PubMed ID: 38760939)
21. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening.
Joung J; Konermann S; Gootenberg JS; Abudayyeh OO; Platt RJ; Brigham MD; Sanjana NE; Zhang F
Nat Protoc; 2017 Apr; 12(4):828-863. PubMed ID: 28333914
[TBL] [Abstract][Full Text] [Related]
22. Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders.
Coutinho MF; Santos JI; Alves S
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27384562
[TBL] [Abstract][Full Text] [Related]
23. Deciphering the Mode of Action of the Processive Polysaccharide Modifying Enzyme Dermatan Sulfate Epimerase 1 by Hydrogen-Deuterium Exchange Mass Spectrometry.
Tykesson E; Mao Y; Maccarana M; Pu Y; Gao J; Lin C; Zaia J; Westergren-Thorsson G; Ellervik U; Malmström L; Malmström A
Chem Sci; 2016 Feb; 7(2):1447-1456. PubMed ID: 26900446
[TBL] [Abstract][Full Text] [Related]
24. Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways.
Azad GK; Tomar RS
Mol Biol Rep; 2014 Aug; 41(8):4865-79. PubMed ID: 24867080
[TBL] [Abstract][Full Text] [Related]
25. Standardization of α-L-iduronidase enzyme assay with Michaelis-Menten kinetics.
Ou L; Herzog TL; Wilmot CM; Whitley CB
Mol Genet Metab; 2014 Feb; 111(2):113-5. PubMed ID: 24332804
[TBL] [Abstract][Full Text] [Related]
26. A genetic model of substrate reduction therapy for mucopolysaccharidosis.
Lamanna WC; Lawrence R; Sarrazin S; Lameda-Diaz C; Gordts PL; Moremen KW; Esko JD
J Biol Chem; 2012 Oct; 287(43):36283-90. PubMed ID: 22952226
[TBL] [Abstract][Full Text] [Related]
27. Putative biological mechanisms of efficiency of substrate reduction therapies for mucopolysaccharidoses.
Banecka-Majkutewicz Z; Jakóbkiewicz-Banecka J; Gabig-Cimińska M; Węgrzyn A; Węgrzyn G
Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):461-8. PubMed ID: 22949095
[TBL] [Abstract][Full Text] [Related]
28. Iduronic acid in chondroitin/dermatan sulfate: biosynthesis and biological function.
Malmström A; Bartolini B; Thelin MA; Pacheco B; Maccarana M
J Histochem Cytochem; 2012 Dec; 60(12):916-25. PubMed ID: 22899863
[TBL] [Abstract][Full Text] [Related]
29. Genistein in Sanfilippo disease: a randomized controlled crossover trial.
de Ruijter J; Valstar MJ; Narajczyk M; Wegrzyn G; Kulik W; Ijlst L; Wagemans T; van der Wal WM; Wijburg FA
Ann Neurol; 2012 Jan; 71(1):110-20. PubMed ID: 22275257
[TBL] [Abstract][Full Text] [Related]
30. Dermatan sulfate epimerase 1-deficient mice have reduced content and changed distribution of iduronic acids in dermatan sulfate and an altered collagen structure in skin.
Maccarana M; Kalamajski S; Kongsgaard M; Magnusson SP; Oldberg A; Malmström A
Mol Cell Biol; 2009 Oct; 29(20):5517-28. PubMed ID: 19687302
[TBL] [Abstract][Full Text] [Related]
31. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.
Trott O; Olson AJ
J Comput Chem; 2010 Jan; 31(2):455-61. PubMed ID: 19499576
[TBL] [Abstract][Full Text] [Related]
32. Two dermatan sulfate epimerases form iduronic acid domains in dermatan sulfate.
Pacheco B; Malmström A; Maccarana M
J Biol Chem; 2009 Apr; 284(15):9788-95. PubMed ID: 19188366
[TBL] [Abstract][Full Text] [Related]
33. Identification of the active site of DS-epimerase 1 and requirement of N-glycosylation for enzyme function.
Pacheco B; Maccarana M; Goodlett DR; Malmström A; Malmström L
J Biol Chem; 2009 Jan; 284(3):1741-7. PubMed ID: 19004833
[TBL] [Abstract][Full Text] [Related]
34. The mucopolysaccharidoses: a success of molecular medicine.
Clarke LA
Expert Rev Mol Med; 2008 Jan; 10():e1. PubMed ID: 18201392
[TBL] [Abstract][Full Text] [Related]
35. Biosynthesis of dermatan sulfate: chondroitin-glucuronate C5-epimerase is identical to SART2.
Maccarana M; Olander B; Malmström J; Tiedemann K; Aebersold R; Lindahl U; Li JP; Malmström A
J Biol Chem; 2006 Apr; 281(17):11560-8. PubMed ID: 16505484
[TBL] [Abstract][Full Text] [Related]
36. Molecular docking of balanol to dynamics snapshots of protein kinase A.
Wong CF; Kua J; Zhang Y; Straatsma TP; McCammon JA
Proteins; 2005 Dec; 61(4):850-8. PubMed ID: 16245317
[TBL] [Abstract][Full Text] [Related]
37. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations.
Duan Y; Wu C; Chowdhury S; Lee MC; Xiong G; Zhang W; Yang R; Cieplak P; Luo R; Lee T; Caldwell J; Wang J; Kollman P
J Comput Chem; 2003 Dec; 24(16):1999-2012. PubMed ID: 14531054
[TBL] [Abstract][Full Text] [Related]
38. A modified uronic acid carbazole reaction.
BITTER T; MUIR HM
Anal Biochem; 1962 Oct; 4():330-4. PubMed ID: 13971270
[No Abstract] [Full Text] [Related]
39. Increasing the precision of comparative models with YASARA NOVA--a self-parameterizing force field.
Krieger E; Koraimann G; Vriend G
Proteins; 2002 May; 47(3):393-402. PubMed ID: 11948792
[TBL] [Abstract][Full Text] [Related]
40. Hexuronyl C5-epimerases in alginate and glycosaminoglycan biosynthesis.
Valla S; Li J; Ertesvåg H; Barbeyron T; Lindahl U
Biochimie; 2001 Aug; 83(8):819-30. PubMed ID: 11530215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
